Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stefan Oelrich
Pharma
Bayer projects Xarelto's sales decline will gain steam in 2025
After Xarelto saw a sales decline of 600 million euros last year because of generic competition, Bayer is projecting a sharper fall in 2025.
Kevin Dunleavy
Mar 5, 2025 11:17am
JPM25: Bayer gears up for 'must-win battles' amid Xarelto decline
Jan 15, 2025 8:00pm
With exec shakeup and new pharma unit, Bayer's reorg takes shape
Mar 20, 2024 2:58pm
As Nubeqa soars, Bayer's Xarelto is struggling in China
Aug 5, 2022 9:09am
With Bayer's new drugs in infancy, Eylea and Xarelto still rule
Mar 1, 2022 10:35am
Bayer bullish on Kerendia after SGLT2 combo showing
Nov 9, 2021 10:15am
